JP2002531517A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002531517A5 JP2002531517A5 JP2000586355A JP2000586355A JP2002531517A5 JP 2002531517 A5 JP2002531517 A5 JP 2002531517A5 JP 2000586355 A JP2000586355 A JP 2000586355A JP 2000586355 A JP2000586355 A JP 2000586355A JP 2002531517 A5 JP2002531517 A5 JP 2002531517A5
- Authority
- JP
- Japan
- Prior art keywords
- osteopontin
- calcification
- cells
- ectopic calcification
- ectopic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/206,576 US6551990B2 (en) | 1998-12-07 | 1998-12-07 | Methods of inhibiting ectopic calcification |
| US09/206,576 | 1998-12-07 | ||
| PCT/US1999/029173 WO2000033865A1 (en) | 1998-12-07 | 1999-12-07 | Methods of inhibiting ectopic calcification |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002531517A JP2002531517A (ja) | 2002-09-24 |
| JP2002531517A5 true JP2002531517A5 (https=) | 2006-12-14 |
Family
ID=22766997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000586355A Pending JP2002531517A (ja) | 1998-12-07 | 1999-12-07 | 異所性石灰化を阻害する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US6551990B2 (https=) |
| EP (1) | EP1135155A1 (https=) |
| JP (1) | JP2002531517A (https=) |
| AU (1) | AU769806B2 (https=) |
| CA (1) | CA2354189A1 (https=) |
| WO (1) | WO2000033865A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001295010A1 (en) * | 2000-08-18 | 2002-03-04 | Case Western Reserve University | Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| AU2003239589A1 (en) * | 2002-05-24 | 2003-12-12 | Schering-Plough Ltd. | Eta-1 gene and methods for use |
| US7678889B2 (en) * | 2002-08-06 | 2010-03-16 | Diadexus, Inc. | Compositions and methods relating to ovarian specific genes and proteins |
| CA2547654C (en) * | 2003-12-01 | 2012-09-25 | Arla Foods Amba | Use of osteopontin in dental formulations |
| JP2008512350A (ja) * | 2004-07-01 | 2008-04-24 | イェール ユニバーシティ | 標的化され、そして高密度で薬物が負荷されるポリマー性物質 |
| US7167746B2 (en) | 2004-07-12 | 2007-01-23 | Ats Medical, Inc. | Anti-coagulation and demineralization system for conductive medical devices |
| US20060276534A1 (en) * | 2005-03-17 | 2006-12-07 | Amgen Inc. | Methods of decreasing calcification |
| US7463758B2 (en) * | 2005-06-02 | 2008-12-09 | Nordio Bioscience A/S | Method of deriving a quantitative measure of a degree of calcification of an aorta |
| US7561727B2 (en) * | 2005-06-02 | 2009-07-14 | Nordic Bioscience Imaging A/S | Method of deriving a quantitative measure of a degree of calcification of an aorta |
| JP5199077B2 (ja) * | 2005-06-10 | 2013-05-15 | アルタス ファーマシューティカルズ インコーポレイテッド | シュウ酸オキシダーゼ結晶の投与による、シュウ酸塩濃度を低下させるための方法 |
| US20070005213A1 (en) * | 2005-06-30 | 2007-01-04 | Hyundai Autonet Co., Ltd. | Backward control for automobiles using telematics and method thereof |
| US20070134229A1 (en) * | 2005-10-11 | 2007-06-14 | Bin Tian | Non-native constitutively active osteopontin |
| AU2006304778B2 (en) * | 2005-10-21 | 2011-04-28 | Amgen Inc. | Methods of decreasing vascular calcification using IL-1 inhibitors |
| US10265407B2 (en) | 2007-02-15 | 2019-04-23 | Yale University | Modular nanodevices for smart adaptable vaccines |
| WO2008109347A2 (en) * | 2007-03-02 | 2008-09-12 | Yale University | Methods for ex vivo administration of drugs to grafts using polymeric nanoparticles |
| AU2008223817A1 (en) * | 2007-03-02 | 2008-09-12 | National University Of Ireland, Galway | Osteopontin for the prediction and treatment of cardiovascular diseases |
| WO2008137281A1 (en) * | 2007-05-03 | 2008-11-13 | Fox Chase Cancer Center | Compositions and methods for altering pancreas or liver function |
| JP5339748B2 (ja) * | 2008-03-11 | 2013-11-13 | 国立大学法人北海道大学 | ヒトオステオポンチンの活性化を阻害する物質をスクリーニングする方法 |
| JP6426001B2 (ja) * | 2011-11-17 | 2018-11-21 | グリア エスピー ゼット．オー．オー． | 神経膠腫を治療するための組成物および方法 |
| US9597385B2 (en) | 2012-04-23 | 2017-03-21 | Allertein Therapeutics, Llc | Nanoparticles for treatment of allergy |
| US9822366B2 (en) | 2012-11-02 | 2017-11-21 | The Brigham And Women's Hospital, Inc. | Sortilin 1 is a novel inducer of vascular calcification |
| WO2014071128A1 (en) * | 2012-11-02 | 2014-05-08 | The Brigham And Women's Hospital, Inc. | Macrophage-derived matrix vesicles: an alternative mechanism for microcalcification in atherosclerotic plaques |
| CN105188741A (zh) | 2013-04-03 | 2015-12-23 | 阿勒丁医疗公司 | 新型纳米颗粒组合物 |
| DK3618845T3 (da) | 2017-05-04 | 2021-04-19 | Follicum Ab | Peptider til behandling af diabetes |
| CN109557309B (zh) * | 2018-12-04 | 2021-09-10 | 九江学院附属医院 | 碳酸酐酶-2作为检测标记物在肾结石诊断方面的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6001350A (en) * | 1987-12-11 | 1999-12-14 | Somatix Therapy Corp | Genetic modification of endothelial cells |
| US5340934A (en) * | 1989-11-03 | 1994-08-23 | The United States Of Americas As Represented By The Secretary Of Health & Human Services | CDNA sequences of human bone matrix proteins |
| US5304496A (en) | 1991-06-10 | 1994-04-19 | Children's Hospital Of Philadelphia | Biological regulation of mineralization |
| WO1994025584A1 (en) * | 1993-04-28 | 1994-11-10 | Johns Hopkins University School Of Medicine | Chronic endothelial cell culture under flow |
| US5824651A (en) | 1993-05-10 | 1998-10-20 | Universite De Montreal | Process for modification of implant surface with bioactive conjugates for improved integration |
| US5695761A (en) | 1993-12-23 | 1997-12-09 | Rutgers University | Suppression of nitric oxide production by osteopontin |
| EP0705842A2 (en) | 1994-10-06 | 1996-04-10 | Hoechst Aktiengesellschaft | Regulated genes by stimulation of chondrocytes with 1L-1beta |
-
1998
- 1998-12-07 US US09/206,576 patent/US6551990B2/en not_active Expired - Fee Related
-
1999
- 1999-12-07 AU AU24783/00A patent/AU769806B2/en not_active Ceased
- 1999-12-07 EP EP99968097A patent/EP1135155A1/en not_active Withdrawn
- 1999-12-07 JP JP2000586355A patent/JP2002531517A/ja active Pending
- 1999-12-07 CA CA002354189A patent/CA2354189A1/en not_active Abandoned
- 1999-12-07 WO PCT/US1999/029173 patent/WO2000033865A1/en not_active Ceased
-
2003
- 2003-02-26 US US10/376,383 patent/US7419950B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7419950B2 (en) | Methods of inhibiting ectopic calcification | |
| JP2002531517A5 (https=) | ||
| Brodkey et al. | The complex nature of interactive neuroregeneration-related molecules | |
| JP3693338B2 (ja) | 組織形成因子誘導による炎症反応の調節 | |
| US5958411A (en) | Methods of inhibiting ECM accumulation in the CNS by inhibition of TGF-β | |
| Xiang et al. | The impact of sitagliptin on macrophage polarity and angiogenesis in the osteointegration of titanium implants in type 2 diabetes | |
| Riches | The multiple roles of macrophages in wound healing | |
| US20120125348A1 (en) | Autologous lymph node transfer in combination with vegf-c or vegf-d growth factor therapy to treat secondary lymphedema and to improve reconstructive surgery | |
| JP3973050B2 (ja) | モルフォゲン誘発性肝再生 | |
| WO1995032709A1 (en) | Activation of growth factors by matrix vesicles | |
| EP2310035B1 (en) | Fibroblast growth factor (fgf) analogs and uses thereof | |
| JPH06172207A (ja) | 肺傷害治療剤 | |
| Williard et al. | Nuclear factor kappa B–dependent gene transcription in cholecystokinin-and tumor necrosis factor-α–stimulated isolated acinar cells is regulated by p38 mitogen-activated protein kinase | |
| JP2023545585A (ja) | 新規の生体活性ペプチドの組み合わせ及びその使用 | |
| US20190105369A1 (en) | Cd31shed agonists for use in the prevention and/or treatment of reperfusion injury | |
| JPWO2007139120A1 (ja) | アミロイドβクリアランス促進剤 | |
| WO2004030689A1 (ja) | 好酸球カチオン性タンパク質を含有する組成物 | |
| JP2008516629A (ja) | 肝細胞増殖因子（ｈｇｆ）の生物活性に関する評価 | |
| US11161887B2 (en) | Uromodulin for use in prevention and therapy of pathological crystallization | |
| Atria | Understanding the Role of Skeletal Stem Cells in Load-Induced Bone Formation, Bone Repair, and Their Relationship With Angiogenesis | |
| JPH07233085A (ja) | 軟骨組織修復治療剤 | |
| Dubose | An in-vitro investigation of thrombospondin-1 induced activation of transforming growth factor beta as a mechanism of controlling corrosion induced fibrous encapsulation | |
| 堀越久子 et al. | Co-administration of adipose-derived stem cells and control-released basic fibroblast growth factor facilitates angiogenesis in a murine ischemic hind limb model | |
| 清水梓 et al. | Effect of control-released basic fibroblast growth factor incorporated in β-tricalcium phosphate for cranial regeneration in a murine model | |
| JP2004035526A (ja) | 創収縮剤及びその製造方法 |